메뉴 건너뛰기




Volumn 59, Issue 1, 2005, Pages 1-2

Editor's page: Extemporaneous quality

(1)  Kirsch, Lee a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG MANUFACTURE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; PHARMACIST; QUALITY CONTROL;

EID: 25144481739     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (2)

References (14)
  • 1
    • 0037268698 scopus 로고    scopus 로고
    • The quandary of compounding for MCOs: Administrative costs, risks, and waste
    • Kaye, T., The Quandary of Compounding for MCOs: Administrative Costs, Risks, and Waste, Managed Care 2003, 42.
    • (2003) Managed Care , pp. 42
    • Kaye, T.1
  • 2
    • 0034236714 scopus 로고    scopus 로고
    • Pharmacy compounding: Customizing prescription drugs
    • Nordenberg, T. Pharmacy Compounding: Customizing Prescription Drugs, FDA Consumer 2000, 11.
    • (2000) FDA Consumer , pp. 11
    • Nordenberg, T.1
  • 4
    • 33746362660 scopus 로고    scopus 로고
    • Pharmacy compounding and the FDA
    • Vivian, J.C., Pharmacy Compounding and the FDA, U.S. Pharmacist 2003, 28:01.
    • (2003) U.S. Pharmacist , vol.28 , pp. 01
    • Vivian, J.C.1
  • 5
    • 25144446551 scopus 로고    scopus 로고
    • Good compounding practices ⇒
    • USP Council of Experts Committee, eds. Good compounding practices ⇒, Pharmacopeial Forum 2002, 28, 640.
    • (2002) Pharmacopeial Forum , vol.28 , pp. 640
  • 6
    • 25144436650 scopus 로고    scopus 로고
    • Compounding and the Supreme Court
    • Vivian, J.C., Compounding and the Supreme Court, U.S. Pharmacist 2002, 27:07.
    • (2002) U.S. Pharmacist , vol.27 , pp. 07
    • Vivian, J.C.1
  • 7
  • 8
    • 0032925395 scopus 로고    scopus 로고
    • Comments on drugs difficult to compound and the quality of chemicals to be used in compounding
    • Perrin, J. H. Comments on drugs difficult to compound and the quality of chemicals to be used in compounding, Drug Development and Industrial Pharmacy 1999, 25(4), 553.
    • (1999) Drug Development and Industrial Pharmacy , vol.25 , Issue.4 , pp. 553
    • Perrin, J.H.1
  • 11
    • 25144464718 scopus 로고    scopus 로고
    • Guidance for FDA staff and industry, pharmacy compounding
    • 460.200
    • FDA, Guidance for FDA Staff and Industry, Pharmacy Compounding, Compliance Policy Guides Manual 2002, 460.200, 1.
    • (2002) Compliance Policy Guides Manual , pp. 1
  • 13
    • 84926233621 scopus 로고    scopus 로고
    • Termination of two food and Drug Administration Advisory Committees
    • Skladany, L. A. Termination of Two Food and Drug Administration Advisory Committees, Federal Register 2002, 67(225), 70227.
    • (2002) Federal Register , vol.67 , Issue.225 , pp. 70227
    • Skladany, L.A.1
  • 14
    • 25144436131 scopus 로고    scopus 로고
    • Compounding pharmacies offered seal of approval
    • Ukens, C., Compounding pharmacies offered seal of approval. Drug Topics 2004, 148, 34.
    • (2004) Drug Topics , vol.148 , pp. 34
    • Ukens, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.